日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanoma.

组织特异性炎症诱导细胞状态可塑性,并在粘膜黑色素瘤中产生致癌依赖性。

Ma Xuhui, Ma Yanni, Zhang Li, Liu Ruixin, Xia Ronghui, Hao Meiling, Song Xiaole, Chen Yinan, Zheng Yang, Wang Hao, Luo Hao, Zheng Shengnan, Yang Jie, Yang Qin, Jiang Ruixin, Chen Xiangyu, Hou Pengcong, Hui Kaiyuan, Bian Qian, Jiang Bin, Jiang Xiaodong, Jiang Min, Zhang Yanjie, Shain A Hunter, Ren Guoxin, Lei Ming, Judson-Torres Robert L, Guo Wei, Zeng Hanlin

RNF39 promotes colorectal cancer progression by driving RINT1 degradation and suppressing ER stress-induced apoptosis

RNF39通过驱动RINT1降解和抑制内质网应激诱导的细胞凋亡来促进结直肠癌的进展。

Chen, Lu; Yuan, Chunluan; Yu, Teng; Hui, Kaiyuan; Li, Xiuming; Shen, Xiaozhu; Jiang, Xiaodong; Liu, Bin

Case Report: Furmonertinib dose escalation in heavily pretreated EGFR-mutant lung adenocarcinoma with diffuse brain metastases

病例报告:呋莫替尼剂量递增治疗既往接受过大量治疗的EGFR突变型肺腺癌伴弥漫性脑转移

Jin, Zian; Dong, Changhong; Hui, Kaiyuan; Jiang, Xiaodong

A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model.

新型抗PD-L1/IL-8双特异性抗体BP2402可增强三阴性乳腺癌小鼠模型的抗肿瘤免疫力并调节炎症信号传导。

Song Liying, Tang Sumin, Pi Xuelei, Yan Yuanyuan, Hu Chenxi, Liu Liang, Chen Hongna, Zhang Yating, Liu Shishi, Yu Dan, Yin Chengkai, Liu Tianyan, Li Xu, Li Deshan, Wang Zhenzhong, Zhu Wei, Hui Kaiyuan, Liu Zhihang, Jiang Xiaodong

Efficacy and safety of PD-1 blockade-activated neoantigen specific cellular therapy for advanced relapsed non-small cell lung cancer

PD-1阻断激活的新抗原特异性细胞疗法治疗晚期复发性非小细胞肺癌的疗效和安全性

Qiao, Yun; Hui, Kaiyuan; Hu, Chenxi; Wang, Mei; Sun, Wen; Liu, Liang; Dong, Changhong; Jiang, Xiaodong

Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer

钾氧酸盐联合抗PD-1治疗结直肠癌

Wang, Yuanyuan; Hu, Chenxi; Du, Tianpeng; Li, Jiawen; Hui, Kaiyuan; Jiang, Xiaodong

RAF1 promotes anlotinib resistance in non-small cell lung cancer by inhibiting apoptosis.

RAF1 通过抑制细胞凋亡促进非小细胞肺癌对安罗替尼的耐药性

Wu Shuo, Hu Chenxi, Hu Pengwu, He Wei, Hui Kaiyuan, Jiang Xiaodong

High CXCL8 expression predicting poor prognosis in triple-negative breast cancer.

CXCL8 高表达预示三阴性乳腺癌预后不良

Tang Sumin, Zhang Yuqing, Song Liying, Hui Kaiyuan, Jiang Xiaodong

POM121 induces chemoresistance toward cisplatin in non-small cell lung cancer

POM121诱导非小细胞肺癌对顺铂产生化疗耐药性

Li, Jiawen; Sun, Wen; Yan, Dongyue; Hui, Kaiyuan; Liu, Yun

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

病例报告:恩伐利单抗联合恩度治疗伴恶性胸腔积液的晚期非小细胞肺癌

Dong, Changhong; Hu, Chenxi; Jiang, Yanting; Hui, Kaiyuan; Jiang, Xiaodong